<a href=https://lasix.mom>lasix
??</a> Although disease specific survival rates approach 98 3, the risk for the development of subsequent invasive breast cancer may reach 30 following local therapy 4, so that patients with DCIS are advised to undertake systemic therapy in the form of oral tamoxifen oral T in order to further reduce the risk of new local breast events